Pomelo Care Raises $92 Million Series C, Reaches $1.7 Billion Valuation, to Expand Its Proven Model Beyond Maternity & Set a New National Standard for Women’s and Children’s Healthcare
Proven to Reduce Preterm Births, NICU Admissions, and Costs, Pomelo Now Covers Nearly 7% of U.S. Births and Is Expanding to Deliver Evidence-Based Care for Women and Children Across Every Stage of Life
NEW YORK, Jan. 8, 2026 /PRNewswire/ — Today, Pomelo Care, the national leader in evidence-based healthcare for women and children, announced it has raised $92 million in Series C funding led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel. Valued at $1.7 billion, Pomelo enters its next chapter after proving that its virtual maternity care model measurably reduces preterm births, NICU admissions, and medical costs at scale. Now supporting nearly 7% of all U.S. births, the company is expanding beyond maternity to bring its proven model to women and children throughout their lives—closing gaps in access and quality, lowering costs, and setting a new national standard for women’s and children’s healthcare.
“Pomelo Care was founded to measurably improve maternal health in the United States,” said Marta Bralic Kerns, founder & CEO of Pomelo Care. “We’ve demonstrated that when care is proactive, evidence-based, and accountable, we improve outcomes and costs come down. Now, with this funding, we’re taking that proven model beyond maternity to build a system of care that supports women and children throughout their lives, delivering better results across the entire healthcare ecosystem—for patients, payers, providers, and employers alike.”
Founded in 2021, Pomelo Care has delivered women’s and children’s healthcare that improves outcomes and lowers costs nationwide. Partnering with leading health plans and employers and now covering more than 25 million lives, Pomelo delivers 24/7 virtual care through a multispecialty clinical team powered by data science to identify risks early, monitor continuously, and close critical gaps. As provider burnout intensifies and care deserts spread, Pomelo has filled the gaps with coordinated care for patients as a trusted peer to practices, delivering quality medical care in collaboration with in-person providers.
-
Clinical Outcomes & Accountability: Pomelo sets a new standard for accountability by publishing and presenting peer-reviewed, claims-based outcomes at leading national scientific and medical conferences, demonstrating results at scale, including:
-
6.8-day reduction in NICU length of stay (16.3 days for complex cases)
-
37% reduction in preterm births
-
46% reduction in emergency room utilization
-
718% higher prenatal depression screening and follow-up rates
-
-
ROI: Engagement with Pomelo is associated with significant reductions in total cost of care for mothers and infants, resulting in a 3-5x ROI for customers. Reductions in preterm births, emergency visits, and NICU stays, three of the most expensive drivers of medical spend, demonstrate Pomelo’s ability to deliver durable savings at scale.
-
Technology: The foundation of Pomelo’s model is its intelligent care platform, which embeds evidence-based care pathways and predictive analytics directly into clinician workflows to surface risks early and update them dynamically as care journeys unfold. This technology enables Pomelo to provide truly proactive care: identifying emerging issues before they escalate and ensuring patients receive timely, personalized care. The platform serves as a clinician co-pilot, providing patient insights, evidence-based playbooks, and recommended clinical actions within minutes, not days. For patients, the platform powers a seamless, supportive experience with 24/7 multimodal (phone, text, call, video, app) access to their multispecialty team of licensed clinicians, including nurses, dietitians, therapists, doulas, and providers who can diagnose, treat, and manage their care.
link
